Showing 2101-2110 of 2652 results for "".
- Gamesquare Partners with Vivior to Help Gamers Build Healthy Screen Habitshttps://modernod.com/news/gamesquare-partners-with-vivior-to-help-gamers-build-healthy-screen-habits/2481646/GameSquare Holdings announced a multi-year, multi-million dollar partnership with Swiss vision care startup Vivior with the aim of promoting healthy digital habits, according to a company news release. Through content creation, product development, and competition, GameSquare and Vivior
- Bausch + Lomb Announces Leadership Changeshttps://modernod.com/news/bausch-lomb-announces-leadership-changes/2481644/Bausch + Lomb announced a reshaping of its executive leadership team, including the elevation of all business unit heads. Luc Bonnefoy, senior vice president (SVP), Surgical; John Ferris, SVP, Consumer; and Yang Yang, SVP, Vision Care; will join the executive management team of the comp
- Market Scope: Improved Vitrectomy Machine Features Expected to Expand Retinal Treatmentshttps://modernod.com/news/market-scope-improved-vitrectomy-machine-features-expected-to-expand-retinal-treatments/2481617/Advancements in vitrectomy machine technology are expected to improve safety and efficacy and enable surgeons to reach a larger population of patients with retinal disease over the next 5 years, according to a Market Scope report. These advancements include small-incision vitrectomy, subretinal t
- Norlase Receives FDA 510(k) Clearance and CE Mark Approval For ECHO Green Pattern Laserhttps://modernod.com/news/norlase-receives-fda-510k-clearance-and-ce-mark-approval-for-echo-green-pattern-laser/2481597/Norlase has received both FDA 510(k) clearance and CE Mark approval for the ECHO Green Pattern Laser photocoagulator. ECHO is a portable scanning laser photocoagulator utilizing MEMS technology. The laser and scanner are completely integrated into a single delivery device that
- Sight Sciences' Glaucoma and Dry Eye Technologies to be Featured in Multiple Clinical Presentations at the 2023 ASCRShttps://modernod.com/news/sight-sciences-glaucoma-and-dry-eye-technologies-to-be-featured-in-multiple-clinical-presentations-at-the-2023-ascrs/2481590/Sight Sciences announced that two of its proprietary glaucoma and dry eye technologies, the Omni Surgical System and the TearCare System, will be featured in oral presentations and one poster at this year's ASCRS annual meeting in San Diego. The Omni Surgical System technology
- Zeiss Receives FDA Approval of the CT Lucia 621P Monofocal IOLhttps://modernod.com/news/zeiss-receives-fda-approval-of-the-ct-lucia-621p-monofocal-iol/2481561/Zeiss announced that the FDA has approved the CT Lucia 621P monofocal IOL, an aspheric, monofocal, single-piece C-loop IOL. The IOL features the patented Zeiss Optic (ZO) Asphericity Concept, which is designed to compensate for a wide range of spherical aberrations and at
- CooperVision Seeks Proposals for 2023 Science and Technology Awardshttps://modernod.com/news/coopervision-seeks-proposals-for-2023-science-and-technology-awards/2481549/CooperVision announced it is now accepting submissions for its 2023 Science and Technology Awards program. The program enables researchers around the world to explore new dimensions in vision care, with the goal of translating innovative ideas into practical solutions. Each year, Cooper
- Mina Sooch Replaced as CEO of Ocuphire Pharma; Claims No Cause was Givenhttps://modernod.com/news/mina-sooch-out-as-ceo-of-ocuphire-pharma-rick-rodgers-to-serve-as-interim-ceo/2481548/Ocuphire Pharma announced on Friday it has parted ways with Mina Sooch as CEO and President. Rick Rodgers, a board member since 2020, was appointed interim CEO and President. Ocuphire said it has retained an executive search firm to assist in identifying a permanent CEO.
- Researchers Explain How Reading Might Contribute to Myopiahttps://modernod.com/news/researchers-explain-how-reading-might-contribute-to-myopia/2481520/Researchers at the State University of New York (SUNY) are publishing a paper explaining how reading might contribute to myopia. In a paper that will be published in the Journal of Vision, scientists demonstrate that the images formed by our eyes during reading lack
- Startup Vedere Bio II Shuts Down After Preclinical Studies Fall Shorthttps://modernod.com/news/startup-vedere-bio-ii-shuts-down-after-preclinical-studies-fall-short/2481512/About 2 years after its launch, gene therapy start-up Vedere Bio II is shutting down. The decision comes after preclinical studies did not meet targets. The announcement was made from the company’s chairman Kevin Bitterman and CEO Cyrus Mozayeni. “We had a bold mission, to d